Bill > HR9251

This bill, titled the "School Access to Naloxone Act of 2026," aims to reduce opioid overdose deaths by providing funding for trained school personnel to administer emergency opioid overdose reversal drugs and devices. It amends the Public Health Service Act to allow grants to eligible entities, such as states or local health departments, which can then provide these grants to elementary and secondary schools. To receive these grants, schools must certify that they will have trained personnel available to administer these life-saving medications, maintain an accessible supply of them, and ensure that state law offers adequate civil liability protection for school staff who administer them in emergencies. "Civil liability protection law" refers to state laws that shield individuals from legal action when providing emergency aid, and "trained personnel" are defined as school nurses, health center staff, or other designated individuals who have received documented training in administering these overdose reversal drugs and devices according to medical standards. The bill also expands the authorization of appropriations to cover these new grant programs.